Featured
nr-axSpA: Breaking the Code
Exhibit Hall, Innovation Theater A
Developed and offered by UCB, Inc.
(Non-CME)
Loading view.
Treating Patients with PsA and AS Today & Tomorrow
Exhibit Hall, Innovation Theater B
Developed and offered by Eli Lilly and Company
(Non-CME)
SAPHNELO® (anifrolumab-fnia): A First-In-Class IFN-1 Signaling Inhibitor, Now With 4-Year Data From a Long-Term Safety and Tolerability Study
Exhibit Hall, Innovation Theater A
Developed and offered by AstraZeneca
(Non-CME)
Get to Know Your Rheumatology Research Foundation
Exhibit Hall, Live Lightning Talks Lounge
Presented by Rhemuatology Research Foundation
(Non-CME)
FORWARD – Advancing Rheumatology Research for over 25 years
Exhibit Hall, Live Lightning Talks Lounge
Presented by National Databank for Rheumatic Diseases
(Non-CME)
Featured Resources: Rheumatology Communication Improvement Aids
Exhibit Hall, Live Lightning Talks Lounge
Presented by AiArthritis
(Non-CME)
Creating Excellence and Equity through Collaboration
Exhibit Hall, Live Lightning Talks Lounge
Presented by Association of Women in Rheumatology
(Non-CME)
A Better Specialty Pharmacy for a Better YOU
Exhibit Hall, Live Lightning Talks Lounge
Presented by Infinity Care Solutions
(Non-CME)
Featured
Updated Guidance Calls for the Earlier Use of Biologics: Are You Embracing the Change?
Exhibit Hall, Innovation Theater B
Developed and offered by GSK
(Non-CME)
Sagebrush Health and Program Overview
Exhibit Hall, Live Lightning Talks Lounge
Presented by Sagebrush Health
(Non-CME)
Q&A, Continue the Conversation
Exhibit Hall, Live Lightning Talks Lounge
Presented by American College of Rheumatology
(Non-CME)
The First FDA-Approved Biologic for the Treatment of Polymyalgia Rheumatica: A Deep Dive
Exhibit Hall, Innovation Theater A
Developed and offered by Sanofi
(Non-CME)
Featured
Expert Perspectives: Identification and Management of Eosinophilic Granulomatosis with Polyangiitis
Exhibit Hall, Innovation Theater B
Developed and offered by GSK
(Non-CME)
Featured
Novartis’ Commitment in Rheumatology
Hilton San Diego Bayfront, 204 (AB)
Developed and offered by Novartis Pharmaceuticals Corporation
(Non-CME)
Featured
Disease Modification: A Roadmap to Slowing Organ Damage Progression in Patients with SLE
Hilton San Diego Bayfront, Sapphire Ballroom A
Developed and offered by GSK
(Non-CME)
Featured
The IL-17 Story: All in the Family
Manchester Grand Hyatt, Harbor Ballroom C
Developed and offered by UCB, Inc.
(Non-CME)
Reaching Beneath the Surface: Exploring treatment that addresses multiple domains with a well-documented safety profile for adult patients with active PsA
Hilton San Diego Bayfront, 202 (AB)
Developed and offered by AbbVie
(Non-CME)